Making Integrated Care Work

Contact Us: 202.684.7457

SAMHSA-HRSA Center for Integrated Health Solutions

View Menu
Glossary
Facebook Twitter Listserve Ask a Question Email

Event

« Back to Calendar of Events

Webinar Details

What is the Evidence for Drug SBIRT in General Health Settings and What Does It Mean?

Start Date: July 01, 2015
End Date: July 01, 2015
Location:
Event Details:

What is the Evidence for Drug SBIRT in General Health Settings and What Does It Mean?
12:00 - 1:30 PM Eastern Time


Overview: The best evidence for the efficacy of any health care intervention comes from randomized controlled trials. SBIRT is designed as both a preventive intervention as well as a treatment (via referral). The best evidence for the efficacy of SBIRT is for hazardous alcohol use in primary care settings. This evidence has been used in support of SBIRT programs in many diverse settings, for patients with more severe conditions and for people who use other drugs. In this webinar we will review the evidence on SBIRT for other drugs, hazardous use of drugs and drug disorders in general health settings. The bulk of the evidence suggests lack of efficacy. Does this mean that drug use should not be identified in general health settings? If drug use is identified what should be done?

Learning objectives:

  1. Participants will be able to describe the randomized controlled trial evidence in the peer-reviewed literature that addresses whether or not drug SBIRT is efficacious in general health settings
  2. Participants will be able to discuss cautions in interpreting such trials
  3. Participants will be able to discuss the implications of the evidence on drug SBIRT for clinical practice and the implementation of SBIRT programs

Dr. Richard Saitz is a general internist and primary care physician, Chair and Professor of Community Health Sciences at Boston University (BU) School of Public Health, and Professor of Medicine at BU School of Medicine. He is a Fellow of the American College of Physicians and of the American Society of Addiction Medicine, and is certified by the American Boards of Internal Medicine and Addiction Medicine.

Register >>

The SAMHSA-HRSA Center for Integrated Health Solutions (CIHS) does not endorse or attest to the quality of the content. Questions regarding content, recordings, and additional information should be directed to the host organization and/or presenter.

Contact Email:
Description:
More Info Url:
Registration Url: http://ireta.org/improve-practice/addiction-professionals/webinars/?utm_source=iContact&utm_medium=email&utm_campaign=IRETA&utm_content=

Call Our Helpline: 202-268-7457

« Back to Calendar of Events

Webinar Details

What is the Evidence for Drug SBIRT in General Health Settings and What Does It Mean?

Start Date: July 01, 2015
End Date: July 01, 2015
Location:
Event Details:

What is the Evidence for Drug SBIRT in General Health Settings and What Does It Mean?
12:00 - 1:30 PM Eastern Time


Overview: The best evidence for the efficacy of any health care intervention comes from randomized controlled trials. SBIRT is designed as both a preventive intervention as well as a treatment (via referral). The best evidence for the efficacy of SBIRT is for hazardous alcohol use in primary care settings. This evidence has been used in support of SBIRT programs in many diverse settings, for patients with more severe conditions and for people who use other drugs. In this webinar we will review the evidence on SBIRT for other drugs, hazardous use of drugs and drug disorders in general health settings. The bulk of the evidence suggests lack of efficacy. Does this mean that drug use should not be identified in general health settings? If drug use is identified what should be done?

Learning objectives:

  1. Participants will be able to describe the randomized controlled trial evidence in the peer-reviewed literature that addresses whether or not drug SBIRT is efficacious in general health settings
  2. Participants will be able to discuss cautions in interpreting such trials
  3. Participants will be able to discuss the implications of the evidence on drug SBIRT for clinical practice and the implementation of SBIRT programs

Dr. Richard Saitz is a general internist and primary care physician, Chair and Professor of Community Health Sciences at Boston University (BU) School of Public Health, and Professor of Medicine at BU School of Medicine. He is a Fellow of the American College of Physicians and of the American Society of Addiction Medicine, and is certified by the American Boards of Internal Medicine and Addiction Medicine.

Register >>

The SAMHSA-HRSA Center for Integrated Health Solutions (CIHS) does not endorse or attest to the quality of the content. Questions regarding content, recordings, and additional information should be directed to the host organization and/or presenter.

Contact Email:
Description:
More Info Url:
Registration Url: http://ireta.org/improve-practice/addiction-professionals/webinars/?utm_source=iContact&utm_medium=email&utm_campaign=IRETA&utm_content=

© 2011 NCBH, all rights reserved.
1400 K Street NW | Suite 400
Washington, D.C. 20005

Email: integration@thenationalcouncil.org

Phone: 202-684-7457